Production (Stage)
Actinium Pharmaceuticals, Inc.
ATNM
$1.64
-$0.06-3.53%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -139.60% | 42.50% | -1.89% | -30.95% | 7.01% |
| Total Depreciation and Amortization | 0.49% | 0.99% | 6.88% | -12.50% | 8.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 637.66% | -10.02% | -2.69% | -0.29% | 48.65% |
| Change in Net Operating Assets | -41.30% | 74.00% | -207.04% | 710.07% | -142.09% |
| Cash from Operations | -31.70% | 51.97% | -50.21% | -8.11% | 1.55% |
| Capital Expenditure | -- | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 33.33% | -50.00% | -100.00% |
| Issuance of Common Stock | -- | -- | -53.76% | -32.59% | 1,138.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 33.33% | -100.07% | -53.77% | -32.60% | 1,138.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -31.66% | 21.96% | -472.00% | -73.15% | 217.23% |